The Lindner Center for Research and Education at The Christ Hospital CRA: Timothy
Welcome,         Profile    Billing    Logout  
 1 Trial 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sweis, Ranya
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
01/25
04/30
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
SCAD, NCT04496687: International Spontaneous Coronary Artery Dissection () "i" Registry

Recruiting
N/A
1000
US, RoW
SCAD Alliance, PERFUSE Study Group
Spontaneous Coronary Artery Dissection
12/25
12/25
Callegari, Emily
NCT04440189: Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

Recruiting
N/A
124
US
GID SVF-2 Device System
GID BIO, Inc.
Osteoarthritis, Knee
12/23
12/24
NCT05756764: Anti-obesity Pharmacotherapy and Inflammation

Active, not recruiting
N/A
30
US
Semaglutide, Glucagon-like peptide-1 receptor (GLP1-R) agonist, Wegovy, Phentermine-Topiramate combination, Qsymia, Phentermine, Lomaira, Adipex-P, Tirzepatide, Mounjaro, Zepbound, GIP/GLP-1 RA, Topiramate, Topamax, Trokendi XR, Qudexy XR, Diethylpropion, Tenuate, Diethylcathinone, Naltrexone/Bupropion, Contrave, Liraglutide, Saxenda, Victoza
Louisiana State University Health Sciences Center in New Orleans, Tulane University, Pennington Biomedical Research Center, Ochsner Health System
Obesity
06/25
07/25
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
Quesada, Odayme
WARRIOR, NCT03417388: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Active, not recruiting
4
2476
US
High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL
University of Florida, United States Department of Defense
Coronary Artery Disease
02/25
09/25
MICRO(T), NCT06139094: MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR

Completed
N/A
48
US
CardioFlux Magnetocardiography
Genetesis Inc.
Ischemic Heart Disease, Coronary Microvascular Disease, Angina
05/24
05/24
MICRO2, NCT06212466: MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA

Recruiting
N/A
135
US
CardioFlux
Genetesis Inc.
Ischemic Heart Disease, Coronary Microvascular Disease, Angina, Myocardial Ischemia
12/24
12/24
DISCOVER INOCA, NCT05288361: The Prospective Multi-center Registry

Recruiting
N/A
500
US
Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire, Acetylcholine Provocation
Yale University, Abbott
Ischemia and No Obstructive Coronary Artery Disease, Coronary Microvascular Dysfunction, Coronary Vasospasm, Endothelial Dysfunction, Microvascular Angina, Chest Pain With Normal Coronary Angiography
12/32
12/32
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
Wulfekotter, Reagan
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
Belback, Madeleine
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
Swift, Sadie
NCT05143177: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis (EVOID-AS)

Active, not recruiting
2/3
867
Canada, US
Evogliptin, DA-1229, Placebo
REDNVIA Co., Ltd.
Calcific Aortic Valve Disease
05/26
12/26
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
Gunasekaran, Prasad
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
Work, Emily
EMPOWER CAD, NCT05755711: Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Active, not recruiting
N/A
399
Europe, US
Shockwave Medical Coronary IVL System
Shockwave Medical, Inc.
Coronary Artery Disease
12/24
04/28
NCT05537753: Encore PFO Closure Device - The PerFOrm Trial

Recruiting
N/A
500
US
Encore PFO closure device, FDA-approved PFO closure device
Encore Medical Inc., Bright Research Partners, Yale Cardiovascular Research Group
Patent Foramen Ovale, Cryptogenic Stroke
04/26
10/30

Download Options